SMAD2 and non-small cell lung carcinoma: Consistent with previous studies showing that the TGF-β pathway is critical for EMT-related acquired EGFR-TKI resistance in NSCLC [8,9], we found higher basal levels of SMAD2 phosphorylation in HCC4006ER cells.